FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W99348004> ?p ?o ?g. }

• W99348004 endingPage "233" @default.
• W99348004 startingPage "229" @default.
• W99348004 abstract "Neoadjuvant chemotherapy is the standard treatment for locally advanced breast cancer. The combination of anthracyclines and taxanes is considered the first choice chemotherapy in advanced breast cancer. We report here the overall results of a phase II study of epirubicin and docetaxel as neoadjuvant chemotherapy in advanced breast cancer.Forty-five patients with locally advanced, nonmetastatic breast carcinoma were treated with epirubicin, 90 mg/m2, docetaxel, 75 mg/m2, intravenously, every 3 weeks for 4 cycles before and 4 cycles after surgery, followed by tamoxifen for 5 years if estrogen receptor positive and radiation therapy if indicated. Patient characteristics included a median age of 45 years; pre Ipostmenopausal, 311/14 patients; T3-T4 in 33, N0/N1 in 12/33; ductal/lobular in 42/3; ER+ in 23; and HER2 overexpression in 23.Clinical response included complete remission in 7 patients and partial remission in 27 (response rate, 75%). All 45 patients underwent surgery (quadrantectomy in 7). Histological examination of the breast and lymph nodes revealed no signs of disease in 3 patients and ductal carcinoma in situ only in 2. Twenty-five patients completed the chemotherapy program. G3-G4 toxicity included neutropenia in 39 patients. No other G3-4 toxicity nor toxic deaths occurred. Median relapse-free and overall survival were 35 and 56 months, respectively.The neoadjuvant treatment was active and well tolerated, but the incidence of pathologic complete remissions was relatively low." @default.
• W99348004 created "2016-06-24" @default.
• W99348004 creator A5008529443 @default.
• W99348004 creator A5012055767 @default.
• W99348004 creator A5021488824 @default.
• W99348004 creator A5024846314 @default.
• W99348004 creator A5043682473 @default.
• W99348004 creator A5054563809 @default.
• W99348004 creator A5066013189 @default.
• W99348004 creator A5070502173 @default.
• W99348004 creator A5075028448 @default.
• W99348004 creator A5075663363 @default.
• W99348004 creator A5080849411 @default.
• W99348004 creator A5089304195 @default.
• W99348004 date "2010-03-01" @default.
• W99348004 modified "2023-09-24" @default.
• W99348004 title "Epirubicin and Docetaxel as Neoadjuvant Treatment of Locally Advanced Breast Cancer: A Phase II Study" @default.
• W99348004 cites W1820276215 @default.
• W99348004 cites W2069878819 @default.
• W99348004 cites W2087354258 @default.
• W99348004 cites W2104337757 @default.
• W99348004 cites W2109079833 @default.
• W99348004 cites W2113242459 @default.
• W99348004 cites W2138154962 @default.
• W99348004 cites W2138222867 @default.
• W99348004 cites W2139248078 @default.
• W99348004 cites W2140654333 @default.
• W99348004 cites W2145081663 @default.
• W99348004 cites W2153158488 @default.
• W99348004 cites W2162628022 @default.
• W99348004 cites W2164774797 @default.
• W99348004 cites W2165371109 @default.
• W99348004 cites W2171958606 @default.
• W99348004 cites W2183598873 @default.
• W99348004 cites W2329273512 @default.
• W99348004 cites W35647293 @default.
• W99348004 doi "https://doi.org/10.1177/030089161009600207" @default.
• W99348004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20572578" @default.
• W99348004 hasPublicationYear "2010" @default.
• W99348004 type Work @default.
• W99348004 sameAs 99348004 @default.
• W99348004 citedByCount "3" @default.
• W99348004 countsByYear W993480042013 @default.
• W99348004 countsByYear W993480042020 @default.
• W99348004 countsByYear W993480042023 @default.
• W99348004 crossrefType "journal-article" @default.
• W99348004 hasAuthorship W99348004A5008529443 @default.
• W99348004 hasAuthorship W99348004A5012055767 @default.
• W99348004 hasAuthorship W99348004A5021488824 @default.
• W99348004 hasAuthorship W99348004A5024846314 @default.
• W99348004 hasAuthorship W99348004A5043682473 @default.
• W99348004 hasAuthorship W99348004A5054563809 @default.
• W99348004 hasAuthorship W99348004A5066013189 @default.
• W99348004 hasAuthorship W99348004A5070502173 @default.
• W99348004 hasAuthorship W99348004A5075028448 @default.
• W99348004 hasAuthorship W99348004A5075663363 @default.
• W99348004 hasAuthorship W99348004A5080849411 @default.
• W99348004 hasAuthorship W99348004A5089304195 @default.
• W99348004 hasConcept C121608353 @default.
• W99348004 hasConcept C126322002 @default.
• W99348004 hasConcept C143998085 @default.
• W99348004 hasConcept C2776694085 @default.
• W99348004 hasConcept C2777176818 @default.
• W99348004 hasConcept C2777757722 @default.
• W99348004 hasConcept C2778115633 @default.
• W99348004 hasConcept C2780835546 @default.
• W99348004 hasConcept C2781190966 @default.
• W99348004 hasConcept C530470458 @default.
• W99348004 hasConcept C71924100 @default.
• W99348004 hasConceptScore W99348004C121608353 @default.
• W99348004 hasConceptScore W99348004C126322002 @default.
• W99348004 hasConceptScore W99348004C143998085 @default.
• W99348004 hasConceptScore W99348004C2776694085 @default.
• W99348004 hasConceptScore W99348004C2777176818 @default.
• W99348004 hasConceptScore W99348004C2777757722 @default.
• W99348004 hasConceptScore W99348004C2778115633 @default.
• W99348004 hasConceptScore W99348004C2780835546 @default.
• W99348004 hasConceptScore W99348004C2781190966 @default.
• W99348004 hasConceptScore W99348004C530470458 @default.
• W99348004 hasConceptScore W99348004C71924100 @default.
• W99348004 hasIssue "2" @default.
• W99348004 hasLocation W993480041 @default.
• W99348004 hasLocation W993480042 @default.
• W99348004 hasOpenAccess W99348004 @default.
• W99348004 hasPrimaryLocation W993480041 @default.
• W99348004 hasRelatedWork W1972094548 @default.
• W99348004 hasRelatedWork W1975750848 @default.
• W99348004 hasRelatedWork W2060666847 @default.
• W99348004 hasRelatedWork W2069548442 @default.
• W99348004 hasRelatedWork W2381518736 @default.
• W99348004 hasRelatedWork W2385399138 @default.
• W99348004 hasRelatedWork W2397786201 @default.
• W99348004 hasRelatedWork W3031289629 @default.
• W99348004 hasRelatedWork W4233995514 @default.
• W99348004 hasRelatedWork W63033637 @default.
• W99348004 hasVolume "96" @default.
• W99348004 isParatext "false" @default.
• W99348004 isRetracted "false" @default.

• next